Be the Match Biotherapies and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
October 10, 2023 at 01:35 am IST
Share
Be The Match BioTherapies and Cryoport announced a new strategic partnership. The collaboration will expand the capabilities of IntegriCell, a standardized bioprocessing, cryopreservation and distribution solution for the global cell therapy market. With cryopreservation facilities in the U.S. and EU, IntegriCell??
is poised to support decentralized and centralized manufacturing models, enabling and accelerating patient access to innovative new therapies. Through this partnership, the companies will provide global bioprocessing and cryopreservation support throughout the U.S. and Europe. The integrated solution combines Be The Match BioTherapies' world-class capabilities for donor identification and collection of high-quality starting material with Cryoport's cryopreservation, bioprocessing and industry leading global logistics capabilities.
The IntegriCell?? solution aims to deliver optimized cellular starting material by providing cell processing, ideally within 24 hours post-collection, using standardized bioprocessing and Cryopreservation protocols performed by experienced teams. This solution will provide cell and gene therapy researchers, developers and manufacturers with consistent starting materials cryopreserved to improve manufacturing slot utilization leading to increased yields bringing new cell and gene therapies to market faster and more affordably.
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Companyâs supply chain solutions enable manufacturers, contract manufacturers (CDMOâs), contract research organizations (CROâs), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.